2m 2m 2m 2m 2m 2m 2m
Editas Medicine (EDIT)
NASDAQ
$3.13-$0.04 (-1.11%)
Price as of Jul 14, 2026 4:44 AM EDT- $484.9MMarket Cap
- 10.88%1-Year Change
- BiotechnologyIndustry
Editas Medicine (EDIT)
$3.13-$0.04 (-1.11%)
EDIT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.16 | ||
Change | -$0.10 (-3.07%) | ||
Open | $3.19 | ||
High | $3.19 | ||
Low | $3.04 | ||
Previous Close | $3.26 | ||
Volume | 2,067,729 | ||
30-Day Average Volume | 3,083,878 | ||
1-Week Change | -13.42% | ||
1-Month Change | 26.40% | ||
1-Year Change | 10.88% | ||
3-Year Change | -64.69% | ||
5-Year Change | -92.79% | ||
Fundamentals | |||
Shares Outstanding | 153.5M | ||
Total Assets | $149.3M | ||
Market Cap | $484.9M | ||
Enterprise Value | $416.0M | ||
Period: QTR TTM FY | |||
Revenue | $2.8M | ||
Net Income | -$25.0M | ||
Free Cash Flow | -$23.2M | ||
EBIT | -$23.9M | ||
EBITDA | -$23.4M | ||
Net Working Capital | $88.3M | ||
EPS | -$0.26 | ||
Enterprise Value/EBITDA | -18 | ||
Enterprise Value/Revenue | 147 | ||
P/B | 110 | ||
P/E | -12 | ||
PEG | 0 | ||
Price/Free Cash Flow | -21 | ||
Price/Operating Cash Flow | -21 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue